nvo market cap by year

Novo Nordisk A-S (NVO) has a market capitalization of $232.8B, based on 4.44B shares at a price of $52.40 (down 1.2% on Friday).

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
December 2025
$52.40
309,963,900
4,443,479,626
$232,838,332,402.40
November 2025
$49.35
458,519,700
4,443,479,626
$219,285,719,543.10
October 2025
$49.46
278,824,400
4,443,479,626
$219,774,502,301.96
September 2025
$55.49
310,264,700
4,446,800,000
$246,752,932,000.00
August 2025
$56.46
418,106,900
4,446,800,000
$251,066,328,000.00
July 2025
$46.55
371,108,700
4,446,800,000
$206,977,195,360.00
June 2025
$68.25
186,234,800
4,446,812,000
$303,497,142,406.00
May 2025
$70.70
239,163,700
4,446,812,000
$314,402,059,473.60
April 2025
$65.71
219,470,000
4,446,812,000
$292,196,014,389.20
March 2025
$68.67
148,675,300
4,446,400,000
$305,315,613,120.00
February 2025
$88.22
167,481,000
4,446,400,000
$392,251,625,920.00
January 2025
$82.18
189,740,600
4,446,400,000
$365,423,382,240.00
December 2024
$83.71
170,270,800
4,460,500,000
$373,397,376,000.00
November 2024
$103.93
121,015,600
4,460,500,000
$463,599,837,250.00
October 2024
$108.95
108,317,800
4,460,500,000
$485,954,971,150.00
September 2024
$115.88
78,552,600
4,460,500,000
$516,861,775,650.00
August 2024
$135.43
90,131,500
4,460,500,000
$604,068,565,100.00
July 2024
$128.59
92,171,100
4,460,500,000
$573,576,141,050.00
June 2024
$138.39
69,209,700
4,465,400,000
$617,976,529,880.00
May 2024
$131.16
83,582,700
4,465,400,000
$585,679,184,760.00
April 2024
$124.40
79,177,500
4,465,400,000
$555,503,351,180.00
March 2024
$124.49
117,271,100
4,470,500,000
$556,528,074,500.00
February 2024
$115.29
105,941,600
4,470,500,000
$515,403,945,000.00
January 2024
$110.45
96,116,000
4,470,500,000
$493,758,678,100.00
December 2023
$99.58
73,612,200
4,477,400,000
$445,861,730,700.00